UCB, Harvard Collaborate on Human Microbiome Research | GenomeWeb

NEW YORK (GenomeWeb News) – UCB today announced a collaboration with researchers at Harvard to study the human microbiome in the intestine.

The project, for which UCB is providing up to $4.5 million in funding over three years, will classify new species found in the human microbiome and study their impact on the immune system. The goal is to identify new drugs for preventing and/or treating immunological diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.